Dybala Juventus Issued Shirt, 2016/17 CL - Signed
Win this black/white Juventus FC home shirt, issued for the phenomenal Argentinian striker Paulo Dybala for the 2016/17 Champions League match.
During the Quarter Finals first leg against Barcellona, "la Joya" was the hands-down protagonist of the match, making two goals and winning against his Argentinian national teammate, Lionel Messi.
Thanks to his talent and unpredictable plays, Juventus made it to the Champions League Final to be held in Cardiff on June 3, 2017. Juve will be up against the current champions Real Madrid.
Dybala even signed the back of the shirt, making it a truly unique piece of memorabilia.
Marco Brunelli, President of the Serie A League presented this shirt to Margherita Granbassi, the AIRC ambassador, at the Charity Gala Dinner supporting breast cancer.
- Short-sleeve, black/white home shirt
- Juventus FC emblem applique on chest
- Sponsored by Adidas
- Scudetto and Coppa Italia patch appliques on front
- Champions League patch applique on right sleeve
- Respect patch applique on left sleeve
- Adizero technology
- Name and number in thin plastic applique
- #21, Size 8
AIRC’s goals are to finance ongoing oncological research, with particular attention given to young researchers, as well as to raise awareness and inform the public.
The Italian Association for Cancer Research (Associazione Italiana per la Ricerca sul Cancro, or AIRC), a private nonprofit association, was founded in 1965 by a group of researchers at the Istituto Tumori in Milan, including Umberto Veronesi and Giuseppe della Porta, with invaluable support from eminent local businesspeople.
From the outset, AIRC has been committed to promoting cancer research in Italy and has gradually expanded to include 17 Regional Committees and 1,462,179 members. These are people whose generosity supports the association and allows it to exist and move forward. AIRC raises funds and gives out grants for cancer research and keeps the public up to date on the latest news in this field.
Funds raised are allocated to research through a rigorous selection process based on merit and transparency. The Scientific Committee, made up of 24 renowned Italian oncologists, assure professionalism in evaluating these research projects and grants.